Learning Objectives
Upon completion of this activity, participants should be able to:
- Compare agents currently used as maintenance therapy in the treatment of mantle cell lymphoma
- Describe novel agents with promise as maintenance therapy in the setting of mantle cell lymphoma
- Contrast prognostic indices and markers used in the treatment of mantle cell lymphoma
- Discuss genomic and proteomic analysis techniques of potential utility in the treatment of mantle cell lymphoma
Topics covered include:
- Introduction to Maintenance Therapy
- Interferon Maintenance Therapy
- Rituximab Maintenance Therapy
- Other Maintenance Therapy Strategies
- Maintenance Therapy and Molecular Remission
- New Developments in Prognostic Measures and Markers
- Genomic and Proteomic Analyses in Mantle Cell Lymphoma
- Summary and Conclusions
Abstract